The U.S. Supreme Court will hear arguments today in the first of two cases this term that consumer advocates fear could shut courthouse doors to patients injured by FDA-approved drugs or medical devices.
Pharmaceutical companies AstraZeneca and Bristol-Myers Squibb Company have been ordered to pay double damages in a case over false mark-ups of U.S. drug prices through 2003.
The popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an increased risk of fractures.
The good news, according to a recent article in Medical Device Week, is that medical technology is moving towards a safe and effective way to remove leads if they become damaged or dangerous to the patient.
Researchers believe that the diabetes drug Avandia may cause bone loss and long-term use may speed up osteoporosis.
Avandia, a drug used by millions of diabetes patients, may contribute to bone loss, according to a new study conducted in mice.
Patients who have the now recalled Medtronic Sprint Fidelis Leads implanted face an important decision. Those who have not suffered from a malfunction must decide whether or not to have the leads capped to avoid having their defibrillator malfunction.
Studies estimate that during the next decade, 100,000 victims in the United States will die of an asbestos related disease - equaling 30 deaths per day.
Ortho Evra Birth Control Patch studies that proved the contraceptive patch exposed women to dangerously high levels of estrogen where either altered or withheld by Johnson & Johnson before the medication was approved by the FDA.
Kathleen Sadlier transferred her mother, Rita, from a hospital to a nursing home, thinking she would get rehabilitation. Instead, her mother received poor care and even an injury.
